Biomedical papers - Ahead of Print

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. X:X | 10.5507/bp.2017.058

Crohn's disease - genetic factors and progress of the disease

Tomas Kupkaa,b, Jarmila Simovab,c, Jana Dvorackovab,d, Lubomir Martinekb,e, Oldrich Motykaf, Magdalena Uvirovab,c, Petr Ditea,b
a Department of Internal Medicine, University Hospital Ostrava, Czech Republic
b Faculty of Medicine, University of Ostrava, Czech Republic
c CGB laborator, a.s., Laboratory of Molecular Genetics and Pathology, Ostrava, Czech Republic
d Institute of Clinical Pathology, University Hospital Ostrava, Czech Republic
e Clinic of Surgery, University Hospital Ostrava, Czech Republic
f Department of Inorganic Analysis, Centre of Nanotechnology, VSB - Technical University of Ostrava, Czech Republic

Background and Objectives. Crohn's disease is a multifactorial inflammatory disease affecting mainly the gastrointestinal tract. The genetic factors that are involved in the disease include mainly three mutations of the gene NOD2/CARD15 (R702W, G908R, 3020insC). The aim of this study was to determine the relationship between the presence of these variants and disease phenotype.

Material and Methods: 70 patients with Crohn's disease were examined for the presence of the above-mentioned mutations. The researchers used the medical records to retrospectively obtain clinical data and together with the information obtained prospectively according to the protocol they analysed the connection between gene mutations and disease phenotype.

Results: At least one mutation was found in 22 patients with Crohn's disease (32%), four patients were found to have two different mutations (composed heterozygotes - 6%) and six patients (9%) were homozygotes for the 3020insC gene. No significant differences were found between the groups with wild-type form and the mutated form of the NOD2 / CARD15 gene with respect to age at the time of diagnosis, form of the disease or localization according to the Montreal classification.

Conclusion: Mutations of the NOD2 / CARD15 gene did not significantly affect the frequency of reoperations, homozygotes with 3020insC gene mutations, however, represented a high risk group. The phenotype was not related significantly to the presence of the examined mutations.

Keywords: Crohn's disease, NOD, CARD15, Montreal classification

Received: September 4, 2017; Accepted: December 19, 2017; Prepublished online: January 18, 2018


References

  1. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777-82. Go to original source... Go to PubMed...
  2. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006;130:650-6. Go to original source... Go to PubMed...
  3. Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, Lakatos PL. Striking elevation in incidence and prevalence of inflammatory  bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol  2004;10:404-9. Go to original source... Go to PubMed...
  4. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA, Bis JC, Bumpstead S, Ellinghaus D, Festen EM, Georges M, Green T, Haritunians T, Jostins L, Latiano A, Mathew CG, Montgomery GW, Prescott NJ, Raychaudhuri S, Rotter JI, Schumm P, Sharma Y, Simms LA, Taylor KD, Whiteman D, Wijmenga C, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Cohen A, Colombel JF, Cottone M, Stronati L, Denson T, De Vos M, D'Inca R, Dubinsky M, Edwards C, Florin T, Franchimont D, Gearry R, Glas J, Van Gossum A, Guthery SL, Halfvarson J, Verspaget HW, Hugot JP, Karban A, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, Mowat C, Newman W, Panés J, Phillips A, Proctor DD, Regueiro M, Russell R, Rutgeerts P, Sanderson J, Sans M, Seibold F, Steinhart AH, Stokkers PC, Torkvist L, Kullak-Ublick G, Wilson D, Walters T, Targan SR, Brant SR, Rioux JD, D'Amato M, Weersma RK, Kugathasan S, Griffiths AM, Mansfield JC, Vermeire S, Duerr RH, Silverberg MS, Satsangi J, Schreiber S, Cho JH, Annese V, Hakonarson H, Daly MJ, Parkes M. Genome-wide meta-Analysis increases to 71 the number of confirmed Crohn´s disease Susceptibility loci. Nat Genet 2010;42:1118-25. Go to original source... Go to PubMed...
  5. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603. Go to original source... Go to PubMed...
  6. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6. Go to original source... Go to PubMed...
  7. Derakhshan F, Naderi N, Farnood A, Firouzi F, Habibi M, Detvany MR, Javeri A, Bahari A, Balaii H, Rad MG, Aghazadeh R, Zali MR. Frequency of three common mutations of CARD15/NOD2 gene in Iranian IBD patiens. Indian J Gastroenterol 2008;27:8-11. Go to PubMed...
  8. Hugot JP, Zaccaria I, Cavanaugh J, Yang H, Vermeire S, Lappalainen M, Schreiber S, Annese V, Jewell DP, Fowler EV, Brant SR, Silverberg MS, Cho J, Rioux JD, Satsangi J, Parkes M; for the IBD International Genetics Consortium. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 2007102(6):1259-67.
  9. Lesage S, Zouali H, Cezard JP. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57. Go to original source... Go to PubMed...
  10. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn´s diesease risk and phenotype in diverse populations: metaanalysis. Am J Gastroenterol 2004;99:2393-404. Go to original source... Go to PubMed...
  11. Kupka T, Simova J, Martinek L, Svoboda P, Klvana P, Bojkova M, Uvirova M, Dovrtelova L, Dite P. Crohnova nemoc - geneticke faktory z pohledu etiopatogeneze. Vnitrni lekarstvi 60(7-8):635-9. (In Czech) Go to PubMed...
  12. Soon IS, Molodecky NA, Rabi DM, Ghali WA, Barkema HW, Kaplan GG. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and metaanalysis. BMC Gastroenterol 2012;12:51. Go to original source... Go to PubMed...
  13. Henckaerts L, Vermeire S. NOD2/CARD15 disease associations other than Crohn's disease. Infl amm Bowel Dis 2007;13(2):235-41. Go to original source... Go to PubMed...
  14. Brant SR,Wang MH, Rawsthorne P, Sargent M, Wu Datta L, Nouvet F, Shugart YY, Bernstein CN. A Population-Based Case-Control Study of CARD15 and Other Risk Factors in Crohn's Disease and Ulcerative Colitis Am J Gastroenterol 2007;102(2):313-23. Go to PubMed...
  15. Helio T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, Farkkila M, Krusius T, Kontula K. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003;52:558-62. Go to original source... Go to PubMed...
  16. Torkvist L, Noble CL, Lordal M, Sjoqvist U, LindForss U, Nimmo E R, Russell R K, Lofberg R, Satsangi J. Contribution of CARD15 variants in determining susceptibility to Crohn's disease in Sweden. Scand J Gastroenterol 2006;41:700-5. Go to original source... Go to PubMed...
  17. Leong, RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP,Sung JJ. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003;17:1465-70. Go to original source... Go to PubMed...
  18. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, Inohara N, Nunez G, Kishi Y, Koike Y, Shimosegawa T, Shimovama T, Hibi T. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91. Go to original source... Go to PubMed...
  19. Barreiro-de-Acosta M, Mendoza JL, Lana R, Dominguez-Mu-oz JE, Diaz-Rubio M. NOD2/CARD15: geographic differences in the Spanish population and clinical applications in Crohn's disease. Rev Esp Enferm Dig 2010;102:321-6. Go to PubMed...
  20. Hradsky O, Lenicek M, Dusatkova P, Bronsky J, Nevoral J, Valtrova V, Kotalova R, Szitanyi P, Petro R, Starzykova V. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs. Tissue antigens 2008;71:538-47. Go to original source... Go to PubMed...
  21. Bhullar M, Macrae F, Brown G, Smith M, Sharpe K. Prediction of Crohn's disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort. World J Gastroenterol 2014;20(17):5008-16 . Go to original source... Go to PubMed...
  22. Long WY, Chen L, Zhang CL, Nong RM, Lin MJ, Zhan LL, Lv XP. Association between NOD2/CARD15 gene polymorphisms and Crohn's disease in Chinese Zhuang patients. World J Gastroenterol 2014;20:4737-44. Go to original source... Go to PubMed...
  23. Vavassori P, Borgiani P, Biancone L, D'Apice M R, Blanco Gdel V, Vallo L, De Nigris F, Monteleone I, Monteleone G, Pallone F, Novelli G. CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease. Inflamm Bowel Dis 2004;10:116-21. Go to original source... Go to PubMed...
  24. Radlmayr M, Torok HP, Martin K, Folwaczny C. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002;122:2091-2. Go to original source... Go to PubMed...
  25. Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Plaza S, Delgado S, Lacy AM, Pique JM, Yagüe J, Panés J. Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 2005;242:693-700. Go to original source... Go to PubMed...
  26. Martinek L, Kupka T, Simova J, Klvana P, Bojkova M, Uvirova M, Zonca, P. NOD2/CARD15 mutations and the risk of reoperation in patients with Crohns disease. Rozhl Chir 2015;94(6):242-6. Go to PubMed...
  27. Lauriola M, Ugolini G, Rivetti S, Nani S, Rosati G, Zanotti S, Montroni I, Manaresi A, Zattoni D, Belluzzi A, Castellani L, D'Uva G, Mattei G, Taffurelli M, Strippoli P, Solmi R. IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. Int J Mol Med 2011;27:469-77. Go to original source... Go to PubMed...
  28. Adler J, Rangwalla SC, Dwamena BA, Higgins PD. The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis. Am J Gastroenterol 2011;106:699-712. Go to original source... Go to PubMed...
  29. Yazdanyar S, Weischer M, Nordestgaard BG. Genotyping for NOD2 Genetic Variants and Crohn Disease: a Metaanalysis. Clinical Chemistry Nov 2009;55(11):1950-7. Go to original source... Go to PubMed...
  30. Salkic NN, Adler G, Zawada I, Alibegovic E, Karakiewicz B, Kozlowska-Wiechowska A, Wasilewicz M, Sulzyc-Bielicka V, Bielickiet D. NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis Bosn J Basic Med Sci 2015;15(2):67-72. Go to original source... Go to PubMed...
  31. Ballauff A, Claßen M, Helmbrecht J, Hubertus J, Hartl D, Koletzko S, Kappler R, Lacher M, Lohse P, Schroepf S, Schweinitz DV, Uhlig HH. NOD2 mutations predict the risk for surgery in pediatric-onset Crohn's disease. J Pediatr Surg 2010;45(8):1591-7. Go to PubMed...
  32. Oldenburg B, Hommes D. Biological therapies in inflammatory bowel disease: top-down or bottom-up? Curr Opin Gastroenterol 2007;23:395-9. Go to original source... Go to PubMed...
  33. Nasir BF, Griffiths LR, Nasir A, Roberts R, Barclay M, Gearry RB, Lea RA. An envirogenomic signature is associated with risk of IBD-related surgery in a population-based Crohn's disease cohort. J Gastrointest Surg 2013;17:1643-50. Go to original source... Go to PubMed...
  34. Lu C, Waugh A, Bailey RJ, Cherry R, Dieleman LA, Gramlich L, Matic K, Millan M, Kroeker KI, Sadowski D, Teshima CW, Todoruk D, Wong C, Wong K, Fedorak RN. Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation. World J Gastroenterol 2012;18:5058-64. Go to original source... Go to PubMed...